Intravenous nicardipine and labetalol use in hypertensive patients with signs or symptoms suggestive of end-organ damage in the emergency department: A subgroup analysis of the CLUE trial

Chad M. Cannon, Phillip Levy, Brigitte M. Baumann, Pierre Borczuk, Abhinav Chandra, David M. Cline, Deborah B. Diercks, Brian Hiestand, Amy Hsu, Preeti Jois, Brian Kaminski, Richard M. Nowak, Jon W. Schrock, Joseph Varon, W. Frank Peacock

Research output: Contribution to journalArticlepeer-review

14 Scopus citations

Fingerprint

Dive into the research topics of 'Intravenous nicardipine and labetalol use in hypertensive patients with signs or symptoms suggestive of end-organ damage in the emergency department: A subgroup analysis of the CLUE trial'. Together they form a unique fingerprint.

Medicine & Life Sciences